Issued 2026-09-25 at $32.54 · now $32.54 (2026-09-25, +0.0% since)
Based on its own history, a month from the 2026-09-25 close, VERA has typically landed between $24.26 and $45.66 — a range of −25.4% to +40.3% from the issuance price $32.54.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
1,325 overlapping 1 month windows · 2021-05-14 – 2026-08-26 · basis climatology · forecast (batch). Base rate up 53.7% (90% CI 51.5–55.9%, ≈1,391 obs). Not a call on this stock — we have no evidence its odds differ.
The cone is anchored at the 2026-09-25 issuance close ($32.54) — the price the forecast resolves against on 2026-10-26, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where VERA has typically landed a month from the 2026-09-25 close of $32.54 — the range is history, not a prediction.
- now $32.54 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $32.21 (-1.0%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $27.86–$36.55
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $24.26–$45.66
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2022-12-06 | −67.5% | −67.5% | +23.3% |
| 2022-12-05 | −66.2% | −66.2% | +26.7% |
| 2022-12-02 | −65.6% | −65.6% | +25.8% |
| 3 best | |||
| 2024-01-18 | +208.2% | +0.0% | +208.2% |
| 2024-01-19 | +199.3% | +0.0% | +207.8% |
| 2024-01-17 | +190.6% | −4.8% | +190.6% |
1,325 overlapping windows · 2021-05-14 – 2026-09-25 · not cherry-picked
Pending catalysts
- November 2027 — Trial primary completion: Phase 2 primary completion: Atacicept in Multiple Glomerular Diseases (source, as of 2026-08-14)
- 2031-05-21 — Trial primary completion: Phase 2 primary completion: A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept (source, as of 2026-08-14)
Public, scheduled events — dated attention, not a prediction of the outcome. See the FDA catalysts page for the historical base rate.
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~6 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-15 | Fordyce Marshall | director | Sale | 18,500 @ $37.00 | $685K | −7.3% of holding | not yet — horizon still open | not yet — horizon still open | 235,244 | Form 4 · filed 2 days after the trade |
| 2026-09-02 | Fordyce Marshall | director | Sale | 18,500 @ $35.12 | $650K | −7.3% of holding | not yet — horizon still open | not yet — horizon still open | 235,244 | Form 4 · filed 2 days after the trade |
| 2026-07-07 | Fordyce Marshall | director | Sale | 32,550 @ $42.07 | $1.4M | −16.5% of holding | −32.3% | not yet — horizon still open | 164,694 | Form 4 · filed 2 days after the trade |
| 2026-07-07 | Fordyce Marshall | director | Sale | 10,500 @ $42.86 | $450K | −6.4% of holding | −32.3% | not yet — horizon still open | 154,194 | Form 4 · filed 2 days after the trade |
| 2026-07-07 | Fordyce Marshall | director | Sale | 2,200 @ $43.59 | $96K | −1.4% of holding | −32.3% | not yet — horizon still open | 151,994 | Form 4 · filed 2 days after the trade |
| 2026-07-07 | Fordyce Marshall | director | Sale | 1,000 @ $40.78 | $41K | −0.5% of holding | −32.3% | not yet — horizon still open | 197,244 | Form 4 · filed 2 days after the trade |
| 2026-06-23 | Fordyce Marshall | director | Sale | 18,412 @ $37.93 | $698K | −8.5% of holding | −5.5% | not yet — horizon still open | 198,332 | Form 4 · filed 1 day after the trade |
| 2026-06-23 | Fordyce Marshall | director | Sale | 88 @ $38.43 | $3K | −0.0% of holding | −5.5% | not yet — horizon still open | 198,244 | Form 4 · filed 1 day after the trade |
| 2026-05-12 | Fordyce Marshall | director | Sale | 14,219 @ $36.64 | $521K | −6.0% of holding | −8.3% | not yet — horizon still open | 221,025 | Form 4 · filed 1 day after the trade |
| 2026-05-12 | Fordyce Marshall | director | Sale | 4,281 @ $37.09 | $159K | −1.9% of holding | −8.3% | not yet — horizon still open | 216,744 | Form 4 · filed 1 day after the trade |
| 2026-04-14 | Fordyce Marshall | director | Sale | 14,130 @ $43.66 | $617K | −5.5% of holding | −18.6% | not yet — horizon still open | 244,065 | Form 4 · filed 1 day after the trade |
| 2026-04-14 | Fordyce Marshall | director | Sale | 7,921 @ $44.58 | $353K | −3.2% of holding | −18.6% | not yet — horizon still open | 236,144 | Form 4 · filed 1 day after the trade |
| 2026-04-14 | Fordyce Marshall | director | Sale | 900 @ $45.51 | $41K | −0.4% of holding | −18.6% | not yet — horizon still open | 235,244 | Form 4 · filed 1 day after the trade |
| 2026-02-23 | Fordyce Marshall | director | Sale | 16,925 @ $41.98 | $711K | −6.2% of holding | −1.5% | −32.3% | 257,163 | Form 4 · filed 2 days after the trade |
| 2026-02-23 | Grant Sean | officer | Sale | 4,949 @ $41.98 | $208K | −4.2% of holding | −1.5% | −32.3% | 114,181 | Form 4 · filed 2 days after the trade |
| 2026-02-23 | Young Joseph R | officer | Sale | 3,117 @ $41.98 | $131K | −4.6% of holding | −1.5% | −32.3% | 64,722 | Form 4 · filed 2 days after the trade |
| 2026-02-23 | JOHNSON DAVID LEE | director | Sale | 2,579 @ $41.98 | $108K | −5.3% of holding | −1.5% | −32.3% | 45,727 | Form 4 · filed 2 days after the trade |
| 2026-02-23 | Turner William D. | officer | Sale | 2,187 @ $41.98 | $92K | −4.6% of holding | −1.5% | −32.3% | 45,313 | Form 4 · filed 2 days after the trade |
| 2026-02-23 | Brenner Robert | officer | Sale | 2,151 @ $41.98 | $90K | −4.1% of holding | −1.5% | −32.3% | 50,947 | Form 4 · filed 2 days after the trade |
| 2026-02-23 | Skelton Laurence Matthew | officer | Sale | 1,582 @ $41.98 | $66K | −2.4% of holding | −1.5% | −32.3% | 64,218 | Form 4 · filed 2 days after the trade |
| 2025-12-15 | Turner William D. | officer | Sale | 10,000 @ $50.08 | $501K | −30.8% of holding | −7.9% | −38.3% | 22,500 | Form 4 · filed 2 days after the trade |
| 2025-12-11 | ENRIGHT PATRICK G | director | Purchase | 5,882 @ $42.50 | $250K | ownership Δ n/a | +5.7% | −35.7% | 5,882 | Form 4 · filed 4 days after the trade |
| 2025-12-08 | Turner William D. | officer | Sale | 10,000 @ $45.31 | $453K | −30.8% of holding | +4.7% | −36.5% | 22,500 | Form 4 · filed 2 days after the trade |
| 2025-12-03 | Turner William D. | officer | Sale | 10,000 @ $40.00 | $400K | −30.8% of holding | +13.2% | −30.2% | 22,500 | Form 4 · filed 1 day after the trade |
| 2025-11-21 | Carter Jason S | officer | Sale | 3,864 @ $27.82 | $107K | −7.3% of holding | +84.7% | +5.9% | 49,136 | Form 4 · filed 4 days after the trade |
| 2025-11-11 | Young Joseph R | officer | Sale | 15,000 @ $29.06 | $436K | −23.9% of holding | +54.0% | +23.0% | 47,839 | Form 4 · filed 2 days after the trade |
| 2025-06-24 | ENRIGHT PATRICK G | director | Purchase | 27,071 @ $22.35 | $605K | +0.8% of holding | −7.7% | +124.7% | 3,596,593 | Form 4 · filed 1 day after the trade |
| 2025-06-24 | ENRIGHT PATRICK G | director | Purchase | 13,536 @ $22.35 | $303K | +0.8% of holding | −7.7% | +124.7% | 1,797,619 | Form 4 · filed 1 day after the trade |
| 2025-06-23 | ENRIGHT PATRICK G | director | Purchase | 139,595 @ $20.87 | $2.9M | +4.1% of holding | −1.1% | +122.5% | 3,569,522 | Form 4 · filed 2 days after the trade |
| 2025-06-23 | ENRIGHT PATRICK G | director | Purchase | 69,798 @ $20.87 | $1.5M | +4.1% of holding | −1.1% | +122.5% | 1,784,083 | Form 4 · filed 2 days after the trade |
| 2025-02-26 | Fordyce Marshall | director | Sale | 7,975 @ $27.55 | $220K | −3.7% of holding | −0.2% | −29.5% | 205,765 | Form 4 · filed 1 day after the trade |
| 2025-02-26 | Fordyce Marshall | director | Sale | 1,100 @ $28.32 | $31K | −0.5% of holding | −0.2% | −29.5% | 204,665 | Form 4 · filed 1 day after the trade |
| 2025-02-21 | Fordyce Marshall | director | Sale | 10,613 @ $27.89 | $296K | −4.7% of holding | −1.0% | −33.1% | 213,740 | Form 4 · filed 6 days after the trade |
| 2025-01-08 | Fordyce Marshall | director | Sale | 9,975 @ $41.53 | $414K | −6.5% of holding | −17.6% | −51.2% | 143,603 | Form 4 · filed 2 days after the trade |
| 2025-01-08 | Fordyce Marshall | director | Sale | 5,650 @ $42.03 | $237K | −3.8% of holding | −17.6% | −51.2% | 143,603 | Form 4 · filed 2 days after the trade |
| 2025-01-08 | Fordyce Marshall | director | Sale | 1,875 @ $42.00 | $79K | −1.3% of holding | −17.6% | −51.2% | 143,603 | Form 4 · filed 2 days after the trade |
| 2024-12-18 | Fordyce Marshall | director | Sale | 5,023 @ $43.52 | $219K | −5.5% of holding | −22.1% | −48.2% | 85,942 | Form 4 · filed 2 days after the trade |
| 2024-12-18 | Fordyce Marshall | director | Sale | 4,635 @ $44.03 | $204K | −5.1% of holding | −22.1% | −48.2% | 85,942 | Form 4 · filed 2 days after the trade |
| 2024-12-18 | Fordyce Marshall | director | Sale | 3,772 @ $41.33 | $156K | −4.2% of holding | −22.1% | −48.2% | 85,942 | Form 4 · filed 2 days after the trade |
| 2024-12-18 | Fordyce Marshall | director | Sale | 2,195 @ $42.35 | $93K | −2.5% of holding | −22.1% | −48.2% | 85,942 | Form 4 · filed 2 days after the trade |
| 2024-12-18 | Fordyce Marshall | director | Sale | 1,875 @ $43.81 | $82K | −2.1% of holding | −22.1% | −48.2% | 85,942 | Form 4 · filed 2 days after the trade |
| 2024-12-11 | Fordyce Marshall | director | Sale | 14,925 @ $46.91 | $700K | −14.8% of holding | −21.7% | −53.5% | 85,942 | Form 4 · filed 2 days after the trade |
| 2024-12-11 | Fordyce Marshall | director | Sale | 1,775 @ $46.94 | $83K | −2.0% of holding | −21.7% | −53.5% | 85,942 | Form 4 · filed 2 days after the trade |
| 2024-12-11 | Fordyce Marshall | director | Sale | 700 @ $47.55 | $33K | −0.8% of holding | −21.7% | −53.5% | 85,942 | Form 4 · filed 2 days after the trade |
| 2024-12-11 | Fordyce Marshall | director | Sale | 100 @ $47.65 | $5K | −0.1% of holding | −21.7% | −53.5% | 85,942 | Form 4 · filed 2 days after the trade |
| 2024-11-25 | Fordyce Marshall | director | Sale | 7,665 @ $48.18 | $369K | −8.2% of holding | −11.2% | −59.2% | 85,942 | Form 4 · filed 2 days after the trade |
| 2024-11-25 | Fordyce Marshall | director | Sale | 6,579 @ $47.05 | $310K | −7.1% of holding | −11.2% | −59.2% | 85,942 | Form 4 · filed 2 days after the trade |
| 2024-11-25 | Fordyce Marshall | director | Sale | 1,875 @ $49.00 | $92K | −2.1% of holding | −11.2% | −59.2% | 85,942 | Form 4 · filed 2 days after the trade |
| 2024-11-25 | Fordyce Marshall | director | Sale | 1,875 @ $48.76 | $91K | −2.1% of holding | −11.2% | −59.2% | 85,942 | Form 4 · filed 2 days after the trade |
| 2024-11-25 | Fordyce Marshall | director | Sale | 1,381 @ $48.80 | $67K | −1.6% of holding | −11.2% | −59.2% | 85,942 | Form 4 · filed 2 days after the trade |
| 2024-11-13 | Fordyce Marshall | director | Sale | 12,218 @ $49.54 | $605K | −12.4% of holding | −12.1% | −57.7% | 85,942 | Form 4 · filed 2 days after the trade |
| 2024-11-13 | Fordyce Marshall | director | Sale | 7,500 @ $49.00 | $368K | −8.0% of holding | −12.1% | −57.7% | 85,942 | Form 4 · filed 2 days after the trade |
| 2024-11-13 | Fordyce Marshall | director | Sale | 3,307 @ $50.28 | $166K | −3.7% of holding | −12.1% | −57.7% | 85,942 | Form 4 · filed 2 days after the trade |
| 2024-11-13 | Fordyce Marshall | director | Sale | 1,875 @ $49.57 | $93K | −2.1% of holding | −12.1% | −57.7% | 85,942 | Form 4 · filed 2 days after the trade |
| 2024-11-13 | Fordyce Marshall | director | Sale | 1,875 @ $49.52 | $93K | −2.1% of holding | −12.1% | −57.7% | 85,942 | Form 4 · filed 2 days after the trade |
| 2024-11-13 | Fordyce Marshall | director | Sale | 1,875 @ $49.50 | $93K | −2.1% of holding | −12.1% | −57.7% | 85,942 | Form 4 · filed 2 days after the trade |
| 2024-11-13 | Fordyce Marshall | director | Sale | 1,565 @ $49.59 | $78K | −1.8% of holding | −12.1% | −57.7% | 85,942 | Form 4 · filed 2 days after the trade |
| 2024-11-13 | Fordyce Marshall | director | Sale | 310 @ $50.35 | $16K | −0.4% of holding | −12.1% | −57.7% | 85,942 | Form 4 · filed 2 days after the trade |
| 2024-11-13 | Fordyce Marshall | director | Sale | 100 @ $51.20 | $5K | −0.1% of holding | −12.1% | −57.7% | 85,942 | Form 4 · filed 2 days after the trade |
| 2024-10-28 | SEIDENBERG BETH C | director | Sale | 14,798 @ $48.01 | $710K | −10.1% of holding | −3.2% | −46.6% | 131,755 | Form 4 · filed 2 days after the trade |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
155 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-15 | Fordyce Marshall | director | Option exercise | 18,500 | 253,744 | Form 4 |
| 2026-09-15 | Fordyce Marshall | director | Option exercise | 18,500 | 488,801 | Form 4 |
| 2026-09-11 | Young Joseph R | officer | Option exercise | 5,000 | 80,754 | Form 4 |
| 2026-09-11 | Young Joseph R | officer | Option exercise | 5,000 | 33,589 | Form 4 |
| 2026-09-02 | Fordyce Marshall | director | Option exercise | 18,500 | 253,744 | Form 4 |
| 2026-09-02 | Fordyce Marshall | director | Option exercise | 18,500 | 507,301 | Form 4 |
| 2026-08-03 | Boman Nancy Lee | officer | Award / grant | 44,987 | 44,987 | Form 4 |
| 2026-08-03 | Boman Nancy Lee | officer | Award / grant | 63,011 | 63,011 | Form 4 |
| 2026-05-21 | Cheng Andrew | director | Award / grant | 17,084 | 17,084 | Form 4 |
| 2026-05-21 | Hall Kimball | director | Award / grant | 17,084 | 17,084 | Form 4 |
| 2026-05-21 | MORRISSEY MICHAEL | director | Award / grant | 17,084 | 17,084 | Form 4 |
| 2026-05-21 | Meyers James R | director | Award / grant | 17,084 | 17,084 | Form 4 |
| 2026-05-21 | Morrison Scott W | director | Award / grant | 17,084 | 17,084 | Form 4 |
| 2026-05-21 | Oliger Christy J. | director | Award / grant | 17,084 | 17,084 | Form 4 |
| 2026-05-21 | SEIDENBERG BETH C | director | Award / grant | 17,084 | 17,084 | Form 4 |
| 2026-05-21 | ENRIGHT PATRICK G | director | Award / grant | 17,084 | 17,084 | Form 4 |
| 2026-03-23 | Wright-Mitchell Jane | officer | Award / grant | 56,850 | 56,850 | Form 4 |
| 2026-03-23 | Wright-Mitchell Jane | officer | Award / grant | 42,403 | 42,403 | Form 4 |
| 2026-03-13 | Young Joseph R | officer | Option exercise | 10,000 | 75,754 | Form 4 |
| 2026-03-13 | Young Joseph R | officer | Option exercise | 10,000 | 38,589 | Form 4 |
| 2026-03-05 | Hite Christopher | director | Award / grant | 24,937 | 24,937 | Form 4 |
| 2026-02-04 | Young Joseph R | officer | Award / grant | 20,000 | 20,000 | Form 4 |
| 2026-02-04 | Brenner Robert | officer | Award / grant | 25,000 | 53,098 | Form 4 |
| 2026-02-04 | Brenner Robert | officer | Award / grant | 50,000 | 50,000 | Form 4 |
| 2026-02-04 | Fordyce Marshall | director | Award / grant | 68,800 | 274,088 | Form 4 |
| 2026-02-04 | Fordyce Marshall | director | Award / grant | 137,500 | 137,500 | Form 4 |
| 2026-02-04 | Skelton Laurence Matthew | officer | Award / grant | 20,000 | 65,800 | Form 4 |
| 2026-02-04 | Skelton Laurence Matthew | officer | Award / grant | 40,000 | 40,000 | Form 4 |
| 2026-02-04 | Grant Sean | officer | Award / grant | 25,000 | 119,130 | Form 4 |
| 2026-02-04 | Grant Sean | officer | Award / grant | 50,000 | 50,000 | Form 4 |
| 2026-02-04 | Turner William D. | officer | Award / grant | 25,000 | 47,500 | Form 4 |
| 2026-02-04 | Turner William D. | officer | Award / grant | 50,000 | 50,000 | Form 4 |
| 2026-02-04 | JOHNSON DAVID LEE | director | Award / grant | 20,000 | 48,306 | Form 4 |
| 2026-02-04 | JOHNSON DAVID LEE | director | Award / grant | 40,000 | 40,000 | Form 4 |
| 2026-02-04 | Young Joseph R | officer | Award / grant | 10,000 | 67,839 | Form 4 |
| 2025-12-15 | Turner William D. | officer | Option exercise | 10,000 | 32,500 | Form 4 |
| 2025-12-15 | Turner William D. | officer | Option exercise | 10,000 | 245,000 | Form 4 |
| 2025-12-08 | Turner William D. | officer | Option exercise | 10,000 | 32,500 | Form 4 |
| 2025-12-08 | Turner William D. | officer | Option exercise | 10,000 | 255,000 | Form 4 |
| 2025-12-03 | Turner William D. | officer | Option exercise | 10,000 | 32,500 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.